FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

LJ Swinnen

Research Profile

Disorders

Living Beings

Procedures

Chemicals & Drugs

Co-author Network

Publications

TOP 3
LJ Swinnen
Organ transplant-related lymphoma.
LJ Swinnen
Post-transplant lymphoproliferative disorders: implications for acquired immunodeficiency syndrome-associated malignancies.
LJ Swinnen
Transplantation-related lymphoproliferative disorder: a model for human immunodeficiency virus-related lymphomas.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of LJ Swinnen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: LJ Swinnen
Organ transplant-related lymphoma.
Current treatment options in oncology 2001;2(4):301-8.
2001: LJ Swinnen
Post-transplant lymphoproliferative disorders: implications for acquired immunodeficiency syndrome-associated malignancies.
Journal of the National Cancer Institute. Monographs 2001;(28):38-43.
2000: LJ Swinnen
Transplantation-related lymphoproliferative disorder: a model for human immunodeficiency virus-related lymphomas.
Seminars in oncology 2000;27(4):402-8.
2000: Edward Paloyan; LJ Swinnen; A Montoya; VA Lonchyna; H J Sullivan; Edward R Garrity
Lung transplantation for advanced bronchioloalveolar carcinoma confined to the lungs.
Transplantation 2000;69(11):2446-8.
2000: Eric D Hsi; T P Singleton; LJ Swinnen; Dunphy Cherie; Serhan Alkan
Mucosa-associated lymphoid tissue-type lymphomas occurring in post-transplantation patients.
The American journal of surgical pathology 2000;24(1):100-6.
1999: Paola Rizzo; Michele Carbone; Susan G Fisher; CM Matker; LJ Swinnen; Amy Powers; I Di Resta; Serhan Alkan; Harvey I Pass; Richard I Fisher
Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma.
Chest 1999;116(6 Suppl):470S-473S.
1999: LJ Swinnen
Overview of posttransplant B-cell lymphoproliferative disorders.
Seminars in oncology 1999;26(5 Suppl 14):21-5.
1998: Kimberly E Foreman; Serhan Alkan; A E Krueger; Jeffrey Panella; LJ Swinnen; Brian J Nickoloff
Geographically distinct HHV-8 DNA sequences in Saudi Arabian Iatrogenic Kaposi's sarcoma lesions.
The American journal of pathology 1998;153(3):1001-4.
1998: Qian Tao; Richard F Ambinder; LJ Swinnen
Epstein-Barr virus (EBV) variant with a 30-bp deletion at the carboxyl terminus (amino acids 346-355) of latent membrane protein-1 (LMP1) gene is able to transform cells and evade immune surveillance.
The American journal of pathology 1998;152(5):1398-9.
1997: LJ Swinnen
Durable remission after aggressive chemotherapy for post-cardiac transplant lymphoproliferation.
Leukemia & lymphoma 1997;28(1-2):89-101.
1997: LJ Swinnen
Treatment of organ transplant-related lymphoma.
Hematology/oncology clinics of North America 1997;11(5):963-73.
1996: Keith D Robertson; A Manns; LJ Swinnen; jianchao zong; Margaret L Gulley; Richard F Ambinder
CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease.
Blood 1996;88(8):3129-36.
1996: Paul G Murray; LJ Swinnen; CM Constandinou; J M Pyle; T J Carr; J Marie Hardwick; Richard F Ambinder
BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders.
Blood 1996;87(2):706-11.
1996: A Kowal-Vern; LJ Swinnen; JM Pyle; RM Radvany; G Dizikes; M Michalov; Z Molnar
Characterization of postcardiac transplant lymphomas. Histology, immunophenotyping, immunohistochemistry, and gene rearrangement.
Archives of pathology & laboratory medicine 1996;120(1):41-8.
1995: LJ Swinnen; G Martin Mullen; T J Carr; Maria Rosa Costanzo; Richard I Fisher
Aggressive treatment for postcardiac transplant lymphoproliferation.
Blood 1995;86(9):3333-40.
1994: A Kowal-Vern; LJ Swinnen; V Shankey; J Walloch; D Potocki; Susan G Fisher; Z Molnar
Flow and image cytometric DNA analysis of postcardiac transplant lymphomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1994;7(3):332-8.
1993: LJ Swinnen; Richard I Fisher
OKT3 monoclonal antibodies induce interleukin-6 and interleukin-10: a possible cause of lymphoproliferative disorders associated with transplantation.
Current opinion in nephrology and hypertension 1993;2(4):670-8.
1993: LJ Swinnen
Transplant immunosuppression-related malignant lymphomas.
Cancer treatment and research 1993;66():95-110.
1992: M R Costanzo-Nordin; LJ Swinnen; Susan G Fisher; E J O'Sullivan; R Pifarre; Alain Heroux; G Martin Mullen; MR Johnson
Cytomegalovirus infections in heart transplant recipients: relationship to immunosuppression.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1992;11(5):837-46.
1992: Kathy S Albain; LJ Swinnen; L C Erickson; P J Stiff; Susan G Fisher; Richard I Fisher
Cytotoxic synergy of cisplatin with concurrent hydroxyurea and cytarabine: summary of an in vitro model and initial clinical pilot experience.
Seminars in oncology 1992;19(3 Suppl 9):102-9.
1991: LJ Swinnen; Nancy Ellis; L C Erickson
Inhibition of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II)-induced DNA interstand cross-link removal and potentiation of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II) cytotoxicity by hydroxyurea and 1-beta-D-arabinofuranosylcytosine.
Cancer research 1991;51(8):1984-9.
1990: LJ Swinnen; M R Costanzo-Nordin; Susan G Fisher; E J O'Sullivan; MR Johnson; Alain Heroux; G J Dizikes; R Pifarre; Richard I Fisher
Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients.
The New England journal of medicine 1990;323(25):1723-8.
1990: Kathy S Albain; LJ Swinnen; L C Erickson; P J Stiff; Richard I Fisher
Cisplatin preceded by concurrent cytarabine and hydroxyurea: a pilot study based on an in vitro model.
Cancer chemotherapy and pharmacology 1990;27(1):33-40.
1989: LJ Swinnen; Susan G Fisher; L C Erickson
Ultraviolet irradiation produces cytotoxic synergy and increased DNA interstrand crosslinking with cis- and trans-diamminedichloroplatinum(II).
Carcinogenesis 1989;10(8):1465-70.
1989: LJ Swinnen; D M Barnes; Susan G Fisher; Kathy S Albain; Richard I Fisher; L C Erickson
1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linking.
Cancer research 1989;49(6):1383-9.